What is he best known for?
The fields of study he is best known for:
His main research concerns Epidermal growth factor receptor, Cancer research, Growth factor receptor, Monoclonal antibody and Epidermal growth factor.
His work deals with themes such as Signal transduction, Mutant, Downregulation and upregulation and Monoclonal, which intersect with Epidermal growth factor receptor.
His study of Glioma is a part of Cancer research.
The concepts of his Monoclonal antibody study are interwoven with issues in Molecular biology and Transplantation.
His Molecular biology research incorporates elements of Immunohistochemistry and Epitope, Antibody.
He has researched Epidermal growth factor in several fields, including Endocrinology and Growth factor.
His most cited work include:
- Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma (400 citations)
- Targeting the ERBB family in cancer: couples therapy (248 citations)
- Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis (238 citations)
What are the main themes of his work throughout his whole career to date?
Cancer research, Epidermal growth factor receptor, Molecular biology, Antibody and Glioma are his primary areas of study.
His Cancer research study combines topics from a wide range of disciplines, such as Cancer, Protein kinase B, Signal transduction, Receptor tyrosine kinase and Growth factor receptor.
His research integrates issues of Tyrosine kinase, Epidermal growth factor, Transplantation and Panitumumab in his study of Epidermal growth factor receptor.
Terrance Grant Johns combines subjects such as Cancer cell, Receptor, Biochemistry, Epitope and Monoclonal antibody with his study of Molecular biology.
His studies in Receptor integrate themes in fields like Cell culture, Mutant and Cell biology.
His Glioma research is multidisciplinary, incorporating elements of Medulloblastoma, Pathology, Immunology, Stem cell and In vivo.
He most often published in these fields:
- Cancer research (62.11%)
- Epidermal growth factor receptor (35.79%)
- Molecular biology (25.26%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (62.11%)
- Medulloblastoma (7.89%)
- Stem cell (7.37%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cancer research, Medulloblastoma, Stem cell, Glioma and Cancer.
His Cancer research research includes elements of Cell culture, DNA damage, Receptor, Receptor tyrosine kinase and Antibody.
His research integrates issues of Clinical trial and Oncology in his study of Medulloblastoma.
His study on Glioma is mostly dedicated to connecting different topics, such as Epidermal growth factor receptor.
The Epidermal growth factor receptor study combines topics in areas such as Matuzumab, Cetuximab, Panitumumab and Pineoblastoma.
His Cancer research is multidisciplinary, incorporating perspectives in Soft tissue sarcoma, Transcription factor, Microtubule and OLIG2.
Between 2017 and 2021, his most popular works were:
- A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma. (31 citations)
- Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response. (10 citations)
- Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response. (10 citations)
In his most recent research, the most cited papers focused on:
Terrance Grant Johns mostly deals with Cancer research, Stem cell, Growth factor receptor, Immunohistochemistry and ERBB4.
The various areas that Terrance Grant Johns examines in his Cancer research study include Cell cycle checkpoint, DNA damage, Chemotherapy, Cisplatin and Apoptosis.
He interconnects Tubulin, Microtubule, Glioblastoma and Cancer in the investigation of issues within Stem cell.
His work carried out in the field of Growth factor receptor brings together such families of science as Angiogenesis, Tyrosine kinase, Oncogene and Receptor tyrosine kinase, Phosphorylation.
Terrance Grant Johns connects Dystroglycan with Glioma in his research.
His studies in Glioma integrate themes in fields like Central nervous system, Compartment, Receptor, Extracellular matrix and Antibody.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
